A groundbreaking therapy, retatrutide, is generating significant buzz within the weight-loss community as a potential answer for persistent weight problems. This new drug, a dual activator targeting glucagon-like peptide-1 and GIP, appears to exhibit remarkable efficacy in research studies, poten